Metastatic renal cancer, abdominal pain ABDOMEN:LIVER, BILIARY TRACT: No focal hepatic lesions. Decreased signal on in phase imaging suggests parenchymal iron deposition. Enhancing peritoneal nodule anterior to the left hepatic lobe measures 2.5 x 1.9 cm (series 2002, image 66), previously 2.6 x 1.9 cm.SPLEEN: Splenomegaly. Peripherally enhancing cystic mass in the superior spleen measures 5.1 x 4.3 cm (series 2002, image 77), previously 4.5 x 3.8 cm. Rim enhancing perisplenic lesion measures 3.9 x 1.7 cm (series 2002, image 53), previously 2.3 x 1.6 cm.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: Reference enhancing nodule in the superior portion of the left nephrectomy bed measures 2.5 x 1.7 cm (series 2002, image 59), previously 2.0 x 0.8 cm.KIDNEYS, URETERS: Status post left nephrectomy. Ill-defined soft tissue in the left nephrectomy bed measures 3.1 x 2.0 cm (series 2002, image 51), previously 3.2 x 2.1 cm.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: Status post left hemicolectomy with right lower quadrant colostomy.Left lateral body wall rim-enhancing lesion in the superior left paracolic gutter measures 4.8 x 2.5 cm (series 2002, image 33), previously 4.6 x 2.4 cm.BONES, SOFT TISSUES: No significant abnormality noted.PELVIS:PROSTATE, SEMINAL VESICLES: Avid heterogeneous enhancement of enlarged prostate; correlate with PSA.BLADDER: No significant abnormality noted.LYMPH NODES: Enhancing left inguinal lesion measures 2.5 x 1.5 cm (series 2002, image 37), previously 2.2 x 1.3 cm.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.
1.Multiple enhancing metastases with reference measurements as above.2.No new sites of disease.